Biodesix, Inc. (BDSX)
NASDAQ: BDSX · IEX Real-Time Price · USD
1.230
-0.030 (-2.38%)
Apr 26, 2024, 12:11 PM EDT - Market open
Biodesix Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Biodesix stock has a target of 3.50, which predicts an increase of 184.55% from the current stock price of 1.23.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 4, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Biodesix is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +184.55% | Mar 4, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +184.55% | Dec 7, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +306.50% | May 12, 2022 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 20, 2022 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 17, 2021 |
Financial Forecast
Revenue This Year
66.56M
from 49.09M
Increased by 35.59%
Revenue Next Year
80.62M
from 66.56M
Increased by 21.13%
EPS This Year
-0.43
from -0.64
EPS Next Year
-0.33
from -0.43
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 68.8M | 86.6M | 104.4M |
| Avg | 66.6M | 80.6M | 101.4M |
| Low | 63.7M | 74.1M | 97.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 40.1% | 30.2% | 29.5% |
| Avg | 35.6% | 21.1% | 25.8% |
| Low | 29.8% | 11.3% | 20.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.43 | -0.28 | -0.17 |
| Avg | -0.43 | -0.33 | -0.16 |
| Low | -0.43 | -0.37 | -0.16 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.